Increased serum levels of adiponectin in patients with erosive osteoarthritis
Authors:
M. Filková 1; M. Lišková 1; H. Hulejová 1; M. Haluzík 2
; J. Gatterová 1; K. Pavelka 1; L. Šenolt 1
Authors place of work:
Revmatologický ústav, Praha, 2III. interní klinika VFN a 1. LF UK, Praha
1
Published in the journal:
Čes. Revmatol., 16, 2008, No. 3, p. 100-103.
Category:
Original Papers
Summary
Objective:
Adipocytokines are peptides derived from adipose tissue, which are related to complications of obesity. Although obesity represents a significant risk factor of osteoarthritis, there is not much data on relationship between adipocytokines and osteoarthritis, to date.
The aim of the study was to compare levels of selected adipocytokines, adiponectin and resistin, in patients with erosive and nonerosive osteoarthritis of small hand joints.
Patients and methods:
The studied group consisted of 48 patients with erosive osteoarthritis, 27 patients with nonerosive osteoarthritis and 20 healthy volunteers. Sixty-one patients had skeletal scintigraphy in order to determine the inflammation of small hand joints. The serum levels of adipocytokines were measured by ELISA.
Results:
Women only were selected in the study. Their mean age and body mass index, including the prevalence of osteoarthritis of knee and hip joints did not significantly differ. Serum levels of adiponectin were significantly increased in patients with erosive compared to nonerosive osteoarthritis. Levels of resistin and CRP did not significantly differ between the groups of patients with osteoarthritis of small hand joints. Neither serum adiponectin, nor resistin correlated with CRP and had a relationship to inflammation found on three-phase skeletal scintigraphy.
Conclusion:
Increased levels of adiponectin in patients with erosive osteoarthritis, in comparison to nonerosive type, might have some application in the pathogenesis of destructive process.
Key words:
adipocytokines, adiponectin, resistin, erosive osteoarthritis, inflammation
Zdroje
1. Punzi L, Ramonda R, Sfriso P. Erosive osteoarthritis. Best Pract Res Clin Rheumatol 2004; 18: 739–58.
2. Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 723–7.
3. Sowers MF, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002; 10: 595–601.
4. Pearle AD, Scanzello CR, George S, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516–23.
5. Punzi L, Ramonda R, Oliviero F, et al. Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann Rheum Dis 2005; 64: 955–7.
6. Felson DT, Chaisson CE. Understanding the relationship between body weight and osteoarthritis. Baillieres Clin Rheumatol 1997; 11: 671–81.
7. Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996; 23: 1221–6.
8. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–74.
9. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752–61.
10. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547–66.
11. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525–46.
12. Dumond H, Presle N, Terlain B, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003; 48: 3118–29.
13. Presle N, Pottie P, Dumond H, et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006; 14: 690–5.
14. Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006; 1762: 711–8.
15. Simopoulou T, Malizos KN, Iliopoulos D, et al. Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 2007; 15: 872–83.
16. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007; [Epub ahead of print].
17. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990; 33: 1601–10.
18. Olejarova M, Kupka K, Pavelka K, Gatterova J, Stolfa J. Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis. Results of a two-year study. Joint Bone Spine 2000; 67: 107–12.
19. Senolt L, Pavelka K, Housa D, Haluzik M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006; 35: 247–52.
20. Senolt L, Housa D, Vernerova Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007; 66: 458–63.
21. Schaffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. JAMA 2003; 290: 1709–10.
22. Ehling A, Schaffler A, Herfarth H, et al. The potential of adiponectin in driving arthritis. J Immunol 2006; 176: 4468–78.
23. Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006; 21: 1648–56.
24. Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004; 53: 123–9.
Štítky
Dermatology & STDs Paediatric rheumatology Physiotherapist, university degree Internal medicine Cardiology Orthopaedics RheumatologyČlánok vyšiel v časopise
Czech Rheumatology
2008 Číslo 3
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Rhizarthrosis of carpometacarpal (CMC) joint of a thumb
- Diffuse idiopathic skeletal hyperostosis (DISH) in old age, exceptionally deforming disease
- Recent findings in the pathogenesis of post-chlamydial reactive arthritis
- Cricopharyngeal achalasia in myositis